Search

Your search keyword '"Rodgers, Anthony"' showing total 1,521 results
Start Over Author "Rodgers, Anthony"
1,521 results on '"Rodgers, Anthony"'

7. Design Considerations in Development of a Mobile Health Intervention Program: The TEXT ME and TEXTMEDS Experience

Author

Thakkar, Jay, Barry, Tony, Thiagalingam, Aravinda, Redfern, Julie, McEwan, Alistair L, Rodgers, Anthony, and Chow, Clara K

Subjects
Information technology, T58.5-58.64, Public aspects of medicine, RA1-1270
Abstract

BackgroundMobile health (mHealth) has huge potential to deliver preventative health services. However, there is paucity of literature on theoretical constructs, technical, practical, and regulatory considerations that enable delivery of such services. ObjectivesThe objective of this study was to outline the key considerations in the development of a text message-based mHealth program; thus providing broad recommendations and guidance to future researchers designing similar programs. MethodsWe describe the key considerations in designing the intervention with respect to functionality, technical infrastructure, data management, software components, regulatory requirements, and operationalization. We also illustrate some of the potential issues and decision points utilizing our experience of developing text message (short message service, SMS) management systems to support 2 large randomized controlled trials: TEXT messages to improve MEDication adherence & Secondary prevention (TEXTMEDS) and Tobacco, EXercise and dieT MEssages (TEXT ME). ResultsThe steps identified in the development process were: (1) background research and development of the text message bank based on scientific evidence and disease-specific guidelines, (2) pilot testing with target audience and incorporating feedback, (3) software-hardware customization to enable delivery of complex personalized programs using prespecified algorithms, and (4) legal and regulatory considerations. Additional considerations in developing text message management systems include: balancing the use of customized versus preexisting software systems, the level of automation versus need for human inputs, monitoring, ensuring data security, interface flexibility, and the ability for upscaling. ConclusionsA merging of expertise in clinical and behavioral sciences, health and research data management systems, software engineering, and mobile phone regulatory requirements is essential to develop a platform to deliver and manage support programs to hundreds of participants simultaneously as in TEXT ME and TEXTMEDS trials. This research provides broad principles that may assist other researchers in developing mHealth programs.

Published
2016
Full Text
View/download PDF

8. Quantum Gravity Gradiometers for Urban Underground Mapping

Author

King, Thomas, Boddice, Daniel, Luo, Sha, Rahimzadeh, Farough, Rodgers, Anthony, Faramarzi, Asaad, Metje, Nicole, di Prisco, Marco, Series Editor, Chen, Sheng-Hong, Series Editor, Vayas, Ioannis, Series Editor, Kumar Shukla, Sanjay, Series Editor, Sharma, Anuj, Series Editor, Kumar, Nagesh, Series Editor, Wang, Chien Ming, Series Editor, Cui, Zhen-Dong, Series Editor, Wu, Wei, editor, Leung, Chun Fai, editor, Zhou, Yingxin, editor, and Li, Xiaozhao, editor

Published
2024
Full Text
View/download PDF

11. Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial

Author

Rodgers, Anthony, Salam, Abdul, Schutte, Aletta E, Cushman, William C, de Silva, H Asita, Di Tanna, Gian Luca, Grobbee, Diederick E, Narkiewicz, Krzysztof, Ojji, Dike B, Poulter, Neil R, Schlaich, Markus P, Oparil, Suzanne, Spiering, Wilko, Williams, Bryan, Wright, Jackson T, Jr, Lakshman, P, Uluwattage, W, Hay, P, Pereira, T, Amarasena, N, Ranasinghe, G, Gianacas, Chris, Shanthakumar, Mathangi, Liu, Xiaoqiu, Wang, Nelson, Gnanenthiran, Sonali R, and Whelton, Paul K

Published
2024
Full Text
View/download PDF

13. MEMO—A Mobile Phone Depression Prevention Intervention for Adolescents: Development Process and Postprogram Findings on Acceptability From a Randomized Controlled Trial

Author

Whittaker, Robyn, Merry, Sally, Stasiak, Karolina, McDowell, Heather, Doherty, Iain, Shepherd, Matthew, Dorey, Enid, Parag, Varsha, Ameratunga, Shanthi, and Rodgers, Anthony

Subjects
Computer applications to medicine. Medical informatics, R858-859.7, Public aspects of medicine, RA1-1270
Abstract

BackgroundPrevention of the onset of depression in adolescence may prevent social dysfunction, teenage pregnancy, substance abuse, suicide, and mental health conditions in adulthood. New technologies allow delivery of prevention programs scalable to large and disparate populations. ObjectiveTo develop and test the novel mobile phone delivery of a depression prevention intervention for adolescents. We describe the development of the intervention and the results of participants’ self-reported satisfaction with the intervention. MethodsThe intervention was developed from 15 key messages derived from cognitive behavioral therapy (CBT). The program was fully automated and delivered in 2 mobile phone messages/day for 9 weeks, with a mixture of text, video, and cartoon messages and a mobile website. Delivery modalities were guided by social cognitive theory and marketing principles. The intervention was compared with an attention control program of the same number and types of messages on different topics. A double-blind randomized controlled trial was undertaken in high schools in Auckland, New Zealand, from June 2009 to April 2011. ResultsA total of 1348 students (13–17 years of age) volunteered to participate at group sessions in schools, and 855 were eventually randomly assigned to groups. Of these, 835 (97.7%) self-completed follow-up questionnaires at postprogram interviews on satisfaction, perceived usefulness, and adherence to the intervention. Over three-quarters of participants viewed at least half of the messages and 90.7% (379/418) in the intervention group reported they would refer the program to a friend. Intervention group participants said the intervention helped them to be more positive (279/418, 66.7%) and to get rid of negative thoughts (210/418, 50.2%)—significantly higher than proportions in the control group. ConclusionsKey messages from CBT can be delivered by mobile phone, and young people report that these are helpful. Change in clinician-rated depression symptom scores from baseline to 12 months, yet to be completed, will provide evidence on the effectiveness of the intervention. If proven effective, this form of delivery may be useful in many countries lacking widespread mental health services but with extensive mobile phone coverage. ClinicalTrialAustralia New Zealand Clinical Trials Registry (ACTRN): 12609000405213; http://www.anzctr.org.au/trial_view.aspx?ID=83667 (Archived by WebCite at http://www.webcitation.org/64aueRqOb)

Published
2012
Full Text
View/download PDF

14. Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared With Placebo for Initial Treatment of Hypertension

Author

Rodgers, Anthony, Salam, Abdul, Schutte, Aletta E., Cushman, William C., de Silva, H. Asita, Di Tanna, Gian Luca, Grobbee, Diederick, Narkiewicz, Krzysztof, Ojji, Dike B., Poulter, Neil R., Schlaich, Markus P., Oparil, Suzanne, Spiering, Wilko, Williams, Bryan, Wright, Jackson T., Jr., Gutierez, Alexis, Sanni, Aliu, Lakshman, Poopalan, McMullen, Deirdre, Ranasinghe, Gotabhaya, Gianacas, Chris, Shanthakumar, Mathangi, Liu, Xiaoqiu, Wang, Nelson, and Whelton, Paul

Published
2024
Full Text
View/download PDF

15. Protocol for a randomized controlled trial of intensive blood pressure control on cardiovascular risk reduction in patients with atrial fibrillation: Rationale and design of the CRAFT trial

Author

Jiang, Chao, Wang, Zhiyan, Du, Xin, Wang, Yufeng, Gao, Mingyang, Jia, Zhaoxu, Chai, Zhongyi, Yang, Zhiyun, Wang, Chi, He, Liu, Hu, Rong, Lv, Qiang, Wu, Jiahui, Li, Xu, Jia, Changqi, Han, Rong, Arima, Hisatomi, Wang, Xia, Neal, Bruce, Rodgers, Anthony, Hillis, Graham S., Patel, Anushka, Li, Qiang, Dong, Jianzeng, Anderson, Craig S., and Ma, Changsheng

Published
2024
Full Text
View/download PDF

16. A Theory-Based Video Messaging Mobile Phone Intervention for Smoking Cessation: Randomized Controlled Trial

Author

Whittaker, Robyn, Dorey, Enid, Bramley, Dale, Bullen, Chris, Denny, Simon, Elley, C Raina, Maddison, Ralph, McRobbie, Hayden, Parag, Varsha, Rodgers, Anthony, and Salmon, Penny

Subjects
Computer applications to medicine. Medical informatics, R858-859.7, Public aspects of medicine, RA1-1270
Abstract

Background Advances in technology allowed the development of a novel smoking cessation program delivered by video messages sent to mobile phones. This social cognitive theory-based intervention (called “STUB IT”) used observational learning via short video diary messages from role models going through the quitting process to teach behavioral change techniques. Objective The objective of our study was to assess the effectiveness of a multimedia mobile phone intervention for smoking cessation. Methods A randomized controlled trial was conducted with 6-month follow-up. Participants had to be 16 years of age or over, be current daily smokers, be ready to quit, and have a video message-capable phone. Recruitment targeted younger adults predominantly through radio and online advertising. Registration and data collection were completed online, prompted by text messages. The intervention group received an automated package of video and text messages over 6 months that was tailored to self-selected quit date, role model, and timing of messages. Extra messages were available on demand to beat cravings and address lapses. The control group also set a quit date and received a general health video message sent to their phone every 2 weeks. ResultsThe target sample size was not achieved due to difficulty recruiting young adult quitters. Of the 226 randomized participants, 47% (107/226) were female and 24% (54/226) were Maori (indigenous population of New Zealand). Their mean age was 27 years (SD 8.7), and there was a high level of nicotine addiction. Continuous abstinence at 6 months was 26.4% (29/110) in the intervention group and 27.6% (32/116) in the control group (P = .8). Feedback from participants indicated that the support provided by the video role models was important and appreciated. Conclusions This study was not able to demonstrate a statistically significant effect of the complex video messaging mobile phone intervention compared with simple general health video messages via mobile phone. However, there was sufficient positive feedback about the ease of use of this novel intervention, and the support obtained by observing the role model video messages, to warrant further investigation. Trial registration Australian New Zealand Clinical Trials Registry Number: ACTRN12606000476538; http://www.anzctr.org.au/trial_view.aspx?ID=81688 (Archived by WebCite at http://www.webcitation.org/5umMU4sZi)

Published
2011
Full Text
View/download PDF

17. A Multimedia Mobile Phone–Based Youth Smoking Cessation Intervention: Findings From Content Development and Piloting Studies

Author

Whittaker, Robyn, Maddison, Ralph, McRobbie, Hayden, Bullen, Chris, Denny, Simon, Dorey, Enid, Ellis-Pegler, Mary, van Rooyen, Jaco, and Rodgers, Anthony

Subjects
Computer applications to medicine. Medical informatics, R858-859.7, Public aspects of medicine, RA1-1270
Abstract

Background While most young people who smoke want to quit, few access cessation support services. Mobile phone–based cessation programs are ideal for young people: mobile phones are the most common means of peer communication, and messages can be delivered in an anonymous manner, anywhere, anytime. Following the success of our text messaging smoking cessation program, we developed an innovative multimedia mobile phone smoking cessation intervention. Objective The aim of the study was to develop and pilot test a youth-oriented multimedia smoking cessation intervention delivered solely by mobile phone. Methods Development included creating content and building the technology platform. Content development was overseen by an expert group who advised on youth development principles, observational learning (from social cognitive theory), effective smoking cessation interventions, and social marketing. Young people participated in three content development phases (consultation via focus groups and an online survey, content pre-testing, and selection of role models). Video and text messages were then developed, incorporating the findings from this research. Information technology systems were established to support the delivery of the multimedia messages by mobile phone. A pilot study using an abbreviated 4-week program of video and text content tested the reliability of the systems and the acceptability of the intervention. Results Approximately 180 young people participated in the consultation phase. There was a high priority placed on music for relaxation (75%) and an interest in interacting with others in the program (40% would read messages, 36% would read a blog). Findings from the pre-testing phase (n = 41) included the importance of selecting “real” and “honest” role models with believable stories, and an interest in animations (37%). Of the 15 participants who took part in the pilot study, 13 (87%) were available for follow-up interviews at 4 weeks: 12 participants liked the program or liked it most of the time and found the role model to be believable; 7 liked the role model video messages (5 were unsure); 8 used the extra assistance for cravings; and 9 were happy with two messages per day. Nine participants (60%) stopped smoking during the program. Some technical challenges were encountered during the pilot study. Conclusions A multimedia mobile phone smoking cessation program is technically feasible, and the content developed is appropriate for this medium and is acceptable to our target population. These results have informed the design of a 6-month intervention currently being evaluated for its effectiveness in increasing smoking cessation rates in young people.

Published
2008
Full Text
View/download PDF

19. The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorder

Author

Schwartz, Orli S., Amminger, Paul, Baune, Bernard T., Bedi, Gillinder, Berk, Michael, Cotton, Sue M., Daglas-Georgiou, Rothanthi, Glozier, Nick, Harrison, Ben, Hermens, Daniel F., Jennings, Emma, Lagopoulos, Jim, Loo, Colleen, Mallawaarachchi, Sumudu, Martin, Donel, Phelan, Bethany, Read, Nikki, Rodgers, Anthony, Schmaal, Lianne, Somogyi, Andrew A., Thurston, Lily, Weller, Amber, and Davey, Christopher G.

Published
2023
Full Text
View/download PDF

21. Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data

Author

Neuen, Brendon L., Jun, Min, Wick, James, Kotwal, Sradha, Badve, Sunil V., Jardine, Meg J., Gallagher, Martin, Chalmers, John, Nallaiah, Kellie, Perkovic, Vlado, Peiris, David, Rodgers, Anthony, Woodward, Mark, and Ronksley, Paul E.

Published
2024
Full Text
View/download PDF

23. Transforming blood pressure control in primary care through a novel remote decision support strategy based on wearable blood pressure monitoring: The NEXTGEN-BP randomized trial protocol

Author

Gnanenthiran, Sonali R, Tan, Isabella, Atkins, Emily R, Avolio, Alberto, Bennett, Belinda, Chapman, Niamh, Chow, Clara K, Freed, Ruth, Gnjidic, Danijela, Hespe, Charlotte, Kaur, Baldeep, Liu, Huei Ming, Patel, Anushka, Peiris, David, Reid, Christopher M, Schlaich, Markus, Sharman, James E., Stergiou, George S., Usherwood, Tim, Gianacas, Christopher, Rodgers, Anthony, and Schutte, Aletta E

Published
2023
Full Text
View/download PDF

29. Effect of Initial Treatment With a Single Pill Containing Quadruple Combination of Quarter Doses of Blood Pressure Medicines Versus Standard Dose Monotherapy in Patients With Hypertension on Ambulatory Blood Pressure Indices: Results From the QUARTET Study

Author

Nolde, Janis M., Atkins, Emily, Marschner, Simone, Hillis, Graham S., Chalmers, John, Billot, Laurent, Nelson, Mark R., Reid, Christopher M., Hay, Peter, Burke, Michael, Jansen, Shirley, Usherwood, Tim, Rodgers, Anthony, Chow, Clara K., and Schlaich, Markus P.

Published
2023
Full Text
View/download PDF

30. Low-Dose Triple-Pill vs Standard-Care Protocols for Hypertension Treatment in Nigeria: A Randomized Clinical Trial.

Author

Ojji, Dike B., Salam, Abdul, Sani, Mahmoud U., Ogah, Okechukwu S., Schutte, Aletta E., Huffman, Mark D., Pant, Rashmi, Ghosh, Arpita, Dhurjati, Rupasvi, Lakshmi, Josyula K., Ripiye, Nanna. R., Orji, Ikechukwu A., Kana, Shehu A., Abdussalam, Tijjani, Olawumi, Abdulgafar L., Alfa, Isiaka M., Orimolade, Olanike Allison, Ajayi, Moses O., and Rodgers, Anthony

Subjects
BLACK Africans, SYSTOLIC blood pressure, BLOOD pressure, AFRICANS, HYPERTENSION
Abstract

Key Points: Question: Among Black African adults with hypertension, how effective and safe is a low-dose triple-pill protocol compared with standard-care protocol for lowering blood pressure? Findings: In this randomized trial in Nigeria among 300 Black African patients with uncontrolled hypertension who were either untreated or receiving a single blood pressure–lowering drug, treatment with low-dose triple-pill protocol, compared with standard-care protocol, for 6 months significantly reduced home systolic blood pressure (by 5.8 mm Hg), with no increase in discontinuation of trial treatment due to adverse events. Meaning: Compared with standard-care protocol, treatment with a low-dose triple-pill protocol can improve blood pressure lowering. Importance: With the high burden of hypertension in sub-Saharan Africa, there is a need for effective, safe and scalable treatment strategies. Objective: To compare, among Black African adults, the effectiveness and safety of a novel low-dose triple-pill protocol compared with a standard-care protocol for blood pressure lowering. Design and Setting: Randomized, parallel-group, open-label, multicenter trial conducted in public hospital–based family medicine clinics in Nigeria. Participants: Black African adults with uncontrolled hypertension (≥140/90 mm Hg) who were untreated or receiving a single blood pressure–lowering drug. Interventions: Participants were randomly allocated to low-dose triple-pill or standard-care protocols. The triple-pill protocol involved a novel combination of telmisartan, amlodipine, and indapamide in triple one-quarter, one-half, and standard doses (ie, 10/1.25/0.625 mg, 20/2.5/1.25 mg, and 40/5/2.5 mg), with accelerated up-titration. The standard-care protocol was the Nigeria hypertension treatment protocol starting with amlodipine (5 mg). Main Outcomes and Measures: The primary effectiveness outcome was the reduction in home mean systolic blood pressure, and the primary safety outcome was discontinuation of trial treatment due to adverse events, both from randomization to month 6. Results: The first participant was randomized on July 19, 2022, and the last follow-up visit was on July 18, 2024. Among 300 randomized participants (54% female; mean age, 52 years; baseline mean home blood pressure, 151/97 mm Hg; and clinic blood pressure, 156/97 mm Hg), 273 (91%) completed the trial. At month 6, mean home systolic blood pressure was on average 31 mm Hg (95% CI, 28 to 33 mm Hg) lower in the triple-pill protocol group and 26 mm Hg (95% CI, 22 to 28 mm Hg) lower in the standard-care protocol group (adjusted difference, −5.8 mm Hg [95% CI, −8.0 to −3.6]; P <.001]). At month 6, clinic blood pressure control (<140/90 mm Hg) was 82% vs 72% (risk difference, 10% [95% CI, −2% to 20%]) and home blood pressure control (<130/80 mm Hg) was 62% vs 28% (risk difference, 33% [95% CI, 22% to 44%]) in the triple-pill compared with the standard-care protocol group; these were 2 of 21 prespecified secondary effectiveness end points. No participants discontinued trial treatment due to adverse events. Conclusions and Relevance: Among Black African adults with uncontrolled hypertension, a low-dose triple-pill protocol achieved better blood pressure lowering and control with good tolerability compared with the standard-care protocol. Trial Registration: Pan African Clinical Trials Registry Identifier: PACTR202107579572114 This randomized clinical trial compares the effectiveness and safety of a novel low-dose triple-pill protocol, compared with a standard-care protocol, for blood pressure lowering among Black African adults in Nigeria. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

31. Quantum sensing for gravity cartography

Author

Stray, Ben, Lamb, Andrew, Kaushik, Aisha, Vovrosh, Jamie, Rodgers, Anthony, Winch, Jonathan, Hayati, Farzad, Boddice, Daniel, Stabrawa, Artur, Niggebaum, Alexander, Langlois, Mehdi, Lien, Yu-Hung, Lellouch, Samuel, Roshanmanesh, Sanaz, Ridley, Kevin, de Villiers, Geoffrey, Brown, Gareth, Cross, Trevor, Tuckwell, George, Faramarzi, Asaad, Metje, Nicole, Bongs, Kai, and Holynski, Michael

Published
2022
Full Text
View/download PDF

34. 248. Cognitive Outcomes Following a Course of Racemic Ketamine: Results From the Randomised, Active-Controlled Ketamine for Adult Depression Study (KADS)

Author

Martin, Donel, primary, Harvey, Ania, additional, Baune, Bernhard, additional, Berk, Michael, additional, Carter, Gregory, additional, Dong, Vanessa, additional, Glozier, Nick, additional, Glue, Paul, additional, Hood, Sean, additional, Hadzi-Pavlovic, Dusan, additional, Hackett, Maree, additional, Mills, Natalie, additional, Sarma, Shanthi, additional, Somogyi, Andrew, additional, Rodgers, Anthony, additional, and Loo, Colleen, additional

Published
2024
Full Text
View/download PDF

35. Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis

Author

Joseph, Philip, Roshandel, Gholamreza, Gao, Peggy, Pais, Prem, Lonn, Eva, Xavier, Denis, Avezum, Alvaro, Zhu, Jun, Liu, Lisheng, Sliwa, Karen, Gamra, Habib, Bangdiwala, Shrikant I, Teo, Koon, Diaz, Rafael, Dans, Antonio, Lopez-Jaramillo, Patricio, Prabhakaran, Dorairaj, Castellano, Jose Maria, Fuster, Valentin, Rodgers, Anthony, Huffman, Mark D, Bosch, Jackie, Dagenais, Gilles R, Malekzadeh, Reza, and Yusuf, Salim

Published
2021
Full Text
View/download PDF

36. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

Author

Rahimi, Kazem, Bidel, Zeinab, Nazarzadeh, Milad, Copland, Emma, Canoy, Dexter, Wamil, Malgorzata, Majert, Jeannette, McManus, Richard, Adler, Amanda, Agodoa, Larry, Algra, Ale, Asselbergs, Folkert W, Beckett, Nigel S, Berge, Eivind, Black, Henry, Boersma, Eric, Brouwers, Frank P J, Brown, Morris, Brugts, Jasper J, Bulpitt, Christopher J, Byington, Robert P, Cushman, William C, Cutler, Jeffrey, Devereaux, Richard B, Dwyer, Jamie P, Estacio, Ray, Fagard, Robert, Fox, Kim, Fukui, Tsuguya, Gupta, Ajay K, Holman, Rury R, Imai, Yutaka, Ishii, Masao, Julius, Stevo, Kanno, Yoshihiko, Kjeldsen, Sverre E, Kostis, John, Kuramoto, Kizuku, Lanke, Jan, Lewis, Edmund, Lewis, Julia B, Lievre, Michel, Lindholm, Lars H, Lueders, Stephan, MacMahon, Stephen, Mancia, Giuseppe, Matsuzaki, Masunori, Mehlum, Maria H, Nissen, Steven, Ogawa, Hiroshi, Ogihara, Toshio, Ohkubo, Takayoshi, Palmer, Christopher R, Patel, Anushka, Pfeffer, Marc Allan, Pitt, Bertram, Poulter, Neil R, Rakugi, Hiromi, Reboldi, Gianpaolo, Reid, Christopher, Remuzzi, Giuseppe, Ruggenenti, Piero, Saruta, Takao, Schrader, Joachim, Schrier, Robert, Sever, Peter, Sleight, Peter, Staessen, Jan A, Suzuki, Hiromichi, Thijs, Lutgarde, Ueshima, Kenji, Umemoto, Seiji, van Gilst, Wiek H, Verdecchia, Paolo, Wachtell, Kristian, Whelton, Paul, Wing, Lindon, Woodward, Mark, Yui, Yoshiki, Yusuf, Salim, Zanchetti, Alberto, Zhang, Zhen-Yu, Anderson, Craig, Baigent, Colin, Brenner, Barry Morton, Collins, Rory, de Zeeuw, Dick, Lubsen, Jacobus, Malacco, Ettore, Neal, Bruce, Perkovic, Vlado, Rodgers, Anthony, Rothwell, Peter, Salimi-Khorshidi, Gholamreza, Sundström, Johan, Turnbull, Fiona, Viberti, Giancarlo, Wang, Jiguang, Chalmers, John, Davis, Barry R, Pepine, Carl J, and Teo, Koon K

Published
2021
Full Text
View/download PDF

37. Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial

Author

Hung, Andrew, Edison, Armand, Abraham, Angalie E, Xu, Daniel, Bloch, Mark T, Figtree, Gemma, Nolde, Janis M, Black, Andrew, Jansen, Shirley, Biswas, Sinjini, Ajani, Andrew E, Carnagarin, Revathy, Wynne, Dylan, Altman, Mikhail, Thakkar, Jay, Thiagalingam, Aravinda, Klimis, Harry, Chow, Clara K, Atkins, Emily R, Hillis, Graham S, Nelson, Mark R, Reid, Christopher M, Schlaich, Markus P, Hay, Peter, Rogers, Kris, Billot, Laurent, Burke, Michael, Chalmers, John, Neal, Bruce, Patel, Anushka, Usherwood, Tim, Webster, Ruth, and Rodgers, Anthony

Published
2021
Full Text
View/download PDF

38. Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control

Author

Tremblay, Johanne, Haloui, Mounsif, Attaoua, Redha, Tahir, Ramzan, Hishmih, Camil, Harvey, François, Marois-Blanchet, François-Christophe, Long, Carole, Simon, Paul, Santucci, Lara, Hizel, Candan, Chalmers, John, Marre, Michel, Harrap, Stephen, Cífková, Renata, Krajčoviechová, Alena, Matthews, David R., Williams, Bryan, Poulter, Neil, Zoungas, Sophia, Colagiuri, Stephen, Mancia, Giuseppe, Grobbee, Diederick E., Rodgers, Anthony, Liu, Liusheng, Agbessi, Mawussé, Bruat, Vanessa, Favé, Marie-Julie, Harwood, Michelle P., Awadalla, Philip, Woodward, Mark, Hussin, Julie G., and Hamet, Pavel

Published
2021
Full Text
View/download PDF

39. Bayesian inference from terrestrial gravimetry measurements of near-surface anomalies using a bespoke reversible-jump Markov chain Monte Carlo algorithm

Author

Rodgers, Anthony David

Subjects
531, QC Physics, TA Engineering (General). Civil engineering (General)
Abstract

This work describes a Bayesian algorithm developed to tackle the problem of inference from two-dimensional grids of terrestrial gravity measurements. Near-surface voids such as pipelines and tunnels were the motivating application. The forward models used to approximate the gravity signal due to these potentially complex underground anomalies were sums of simple geometrical shapes: the sphere, finite horizontal cylinder and cuboid. The model parameters of these shapes are related non-linearly to the gravity signal. The reversible-jump Markov chain Monte Carlo algorithm was used, allowing changes to the number of objects comprising the forward model. The natural parsimony of the algorithm was shown to be key for obtaining depth information without the need for arbitrary regularisation. Exploring the Bayesian posterior distribution in this way, spatial, geometrical and anomaly mass information can be obtained as outputs from the inference process, given prior information regarding the soil-anomaly density contrast. This was demonstrated both with synthetic noisy gravity and gravity gradient data and with field gravity data obtained using the Scintrex CG-5 commercial gravimeter. The methodology used to obtain field survey data using the CG-5 over multiple days is described, with discussion of the assignment of measurement uncertainty. A 134 point measurement grid was taken above two spatially separate concrete anomalies, for which volume and density information were known. The data was input into the Bayesian inference algorithm, the forward model parameters were successfully inferred within the total uncertainty.

Published
2017

40. Rationale for a New Low-Dose Triple Single Pill Combination for the Treatment of Hypertension

Author

Global Health, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, MS Interne Geneeskunde, Rodgers, Anthony, Salam, Abdul, Cushman, William, de Silva, Asita, Di Tanna, Gian Luca, Gnanenthiran, Sonali R., Grobbee, Diederick, Narkiewicz, Krzysztof, Ojji, Dike, Oparil, Suzanne, Poulter, Neil, Schlaich, Markus P., Schutte, Aletta E., Spiering, Wilko, Williams, Bryan, Wright, Jackson T., Whelton, Paul, Global Health, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, MS Interne Geneeskunde, Rodgers, Anthony, Salam, Abdul, Cushman, William, de Silva, Asita, Di Tanna, Gian Luca, Gnanenthiran, Sonali R., Grobbee, Diederick, Narkiewicz, Krzysztof, Ojji, Dike, Oparil, Suzanne, Poulter, Neil, Schlaich, Markus P., Schutte, Aletta E., Spiering, Wilko, Williams, Bryan, Wright, Jackson T., and Whelton, Paul

Published
2024

41. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study

Author

Roth, Gregory A., Mensah, George A., Johnson, Catherine O., Addolorato, Giovanni, Ammirati, Enrico, Baddour, Larry M., Barengo, Noel C., Beaton, Andrea, Benjamin, Emelia J., Benziger, Catherine P., Bonny, Aime, Brauer, Michael, Brodmann, Marianne, Cahill, Thomas J., Carapetis, Jonathan R., Catapano, Alberico L., Chugh, Sumeet, Cooper, Leslie T., Coresh, Josef, Criqui, Michael H., DeCleene, Nicole K., Eagle, Kim A., Emmons-Bell, Sophia, Feigin, Valery L., Fernández-Sola, Joaquim, Fowkes, F. Gerry R., Gakidou, Emmanuela, Grundy, Scott M., He, Feng J., Howard, George, Hu, Frank, Inker, Lesley, Karthikeyan, Ganesan, Kassebaum, Nicholas J., Koroshetz, Walter J., Lavie, Carl, Lloyd-Jones, Donald, Lu, Hong S., Mirijello, Antonio, Misganaw, Awoke T., Mokdad, Ali H., Moran, Andrew E., Muntner, Paul, Narula, Jagat, Neal, Bruce, Ntsekhe, Mpiko, Oliveira, Gláucia M.M., Otto, Catherine M., Owolabi, Mayowa O., Pratt, Michael, Rajagopalan, Sanjay, Reitsma, Marissa B., Ribeiro, Antonio Luiz P., Rigotti, Nancy A., Rodgers, Anthony, Sable, Craig A., Shakil, Saate S., Sliwa, Karen, Stark, Benjamin A., Sundström, Johan, Timpel, Patrick, Tleyjeh, Imad I., Valgimigli, Marco, Vos, Theo, Whelton, Paul K., Yacoub, Magdi, Zuhlke, Liesl J., Abbasi-Kangevari, Mohsen, Abdi, Alireza, Abedi, Aidin, Aboyans, Victor, Abrha, Woldu A., Abu-Gharbieh, Eman, Abushouk, Abdelrahman I., Acharya, Dilaram, Adair, Tim, Adebayo, Oladimeji M., Ademi, Zanfina, Advani, Shailesh M., Afshari, Khashayar, Afshin, Ashkan, Agarwal, Gina, Agasthi, Pradyumna, Ahmad, Sohail, Ahmadi, Sepideh, Ahmed, Muktar B., Aji, Budi, Akalu, Yonas, Akande-Sholabi, Wuraola, Aklilu, Addis, Akunna, Chisom J., Alahdab, Fares, Al-Eyadhy, Ayman, Alhabib, Khalid F., Alif, Sheikh M., Alipour, Vahid, Aljunid, Syed M., Alla, François, Almasi-Hashiani, Amir, Almustanyir, Sami, Al-Raddadi, Rajaa M., Amegah, Adeladza K., Amini, Saeed, Aminorroaya, Arya, Amu, Hubert, Amugsi, Dickson A., Ancuceanu, Robert, Anderlini, Deanna, Andrei, Tudorel, Andrei, Catalina Liliana, Ansari-Moghaddam, Alireza, Anteneh, Zelalem A., Antonazzo, Ippazio Cosimo, Antony, Benny, Anwer, Razique, Appiah, Lambert T., Arabloo, Jalal, Ärnlöv, Johan, Artanti, Kurnia D., Ataro, Zerihun, Ausloos, Marcel, Avila-Burgos, Leticia, Awan, Asma T., Awoke, Mamaru A., Ayele, Henok T., Ayza, Muluken A., Azari, Samad, B, Darshan B., Baheiraei, Nafiseh, Baig, Atif A., Bakhtiari, Ahad, Banach, Maciej, Banik, Palash C., Baptista, Emerson A., Barboza, Miguel A., Barua, Lingkan, Basu, Sanjay, Bedi, Neeraj, Béjot, Yannick, Bennett, Derrick A., Bensenor, Isabela M., Berman, Adam E., Bezabih, Yihienew M., Bhagavathula, Akshaya S., Bhaskar, Sonu, Bhattacharyya, Krittika, Bijani, Ali, Bikbov, Boris, Birhanu, Mulugeta M., Boloor, Archith, Brant, Luisa C., Brenner, Hermann, Briko, Nikolay I., Butt, Zahid A., Caetano dos Santos, Florentino Luciano, Cahill, Leah E., Cahuana-Hurtado, Lucero, Cámera, Luis A., Campos-Nonato, Ismael R., Cantu-Brito, Carlos, Car, Josip, Carrero, Juan J., Carvalho, Felix, Castañeda-Orjuela, Carlos A., Catalá-López, Ferrán, Cerin, Ester, Charan, Jaykaran, Chattu, Vijay Kumar, Chen, Simiao, Chin, Ken L., Choi, Jee-Young J., Chu, Dinh-Toi, Chung, Sheng-Chia, Cirillo, Massimo, Coffey, Sean, Conti, Sara, Costa, Vera M., Cundiff, David K., Dadras, Omid, Dagnew, Baye, Dai, Xiaochen, Damasceno, Albertino A.M., Dandona, Lalit, Dandona, Rakhi, Davletov, Kairat, De la Cruz-Góngora, Vanessa, De la Hoz, Fernando P., De Neve, Jan-Walter, Denova-Gutiérrez, Edgar, Derbew Molla, Meseret, Derseh, Behailu T., Desai, Rupak, Deuschl, Günther, Dharmaratne, Samath D., Dhimal, Meghnath, Dhungana, Raja Ram, Dianatinasab, Mostafa, Diaz, Daniel, Djalalinia, Shirin, Dokova, Klara, Douiri, Abdel, Duncan, Bruce B., Duraes, Andre R., Eagan, Arielle W., Ebtehaj, Sanam, Eftekhari, Aziz, Eftekharzadeh, Sahar, Ekholuenetale, Michael, El Nahas, Nevine, Elgendy, Islam Y., Elhadi, Muhammed, El-Jaafary, Shaimaa I., Esteghamati, Sadaf, Etisso, Atkilt E., Eyawo, Oghenowede, Fadhil, Ibtihal, Faraon, Emerito Jose A., Faris, Pawan S., Farwati, Medhat, Farzadfar, Farshad, Fernandes, Eduarda, Fernandez Prendes, Carlota, Ferrara, Pietro, Filip, Irina, Fischer, Florian, Flood, David, Fukumoto, Takeshi, Gad, Mohamed M., Gaidhane, Shilpa, Ganji, Morsaleh, Garg, Jalaj, Gebre, Abadi K., Gebregiorgis, Birhan G., Gebregzabiher, Kidane Z., Gebremeskel, Gebreamlak G., Getacher, Lemma, Obsa, Abera Getachew, Ghajar, Alireza, Ghashghaee, Ahmad, Ghith, Nermin, Giampaoli, Simona, Gilani, Syed Amir, Gill, Paramjit S., Gillum, Richard F., Glushkova, Ekaterina V., Gnedovskaya, Elena V., Golechha, Mahaveer, Gonfa, Kebebe B., Goudarzian, Amir Hossein, Goulart, Alessandra C., Guadamuz, Jenny S., Guha, Avirup, Guo, Yuming, Gupta, Rajeev, Hachinski, Vladimir, Hafezi-Nejad, Nima, Haile, Teklehaimanot G., Hamadeh, Randah R., Hamidi, Samer, Hankey, Graeme J., Hargono, Arief, Hartono, Risky K., Hashemian, Maryam, Hashi, Abdiwahab, Hassan, Shoaib, Hassen, Hamid Y., Havmoeller, Rasmus J., Hay, Simon I., Hayat, Khezar, Heidari, Golnaz, Herteliu, Claudiu, Holla, Ramesh, Hosseini, Mostafa, Hosseinzadeh, Mehdi, Hostiuc, Mihaela, Hostiuc, Sorin, Househ, Mowafa, Huang, Junjie, Humayun, Ayesha, Iavicoli, Ivo, Ibeneme, Charles U., Ibitoye, Segun E., Ilesanmi, Olayinka S., Ilic, Irena M., Ilic, Milena D., Iqbal, Usman, Irvani, Seyed Sina N., Islam, Sheikh Mohammed Shariful, Islam, Rakibul M., Iso, Hiroyasu, Iwagami, Masao, Jain, Vardhmaan, Javaheri, Tahereh, Jayapal, Sathish Kumar, Jayaram, Shubha, Jayawardena, Ranil, Jeemon, Panniyammakal, Jha, Ravi P., Jonas, Jost B., Jonnagaddala, Jitendra, Joukar, Farahnaz, Jozwiak, Jacek J., Jürisson, Mikk, Kabir, Ali, Kahlon, Tanvir, Kalani, Rizwan, Kalhor, Rohollah, Kamath, Ashwin, Kamel, Ibrahim, Kandel, Himal, Kandel, Amit, Karch, André, Kasa, Ayele Semachew, Katoto, Patrick D.M.C., Kayode, Gbenga A., Khader, Yousef S., Khammarnia, Mohammad, Khan, Muhammad S., Khan, Md Nuruzzaman, Khan, Maseer, Khan, Ejaz A., Khatab, Khaled, Kibria, Gulam M.A., Kim, Yun Jin, Kim, Gyu Ri, Kimokoti, Ruth W., Kisa, Sezer, Kisa, Adnan, Kivimäki, Mika, Kolte, Dhaval, Koolivand, Ali, Korshunov, Vladimir A., Koulmane Laxminarayana, Sindhura Lakshmi, Koyanagi, Ai, Krishan, Kewal, Krishnamoorthy, Vijay, Kuate Defo, Barthelemy, Kucuk Bicer, Burcu, Kulkarni, Vaman, Kumar, G. Anil, Kumar, Nithin, Kurmi, Om P., Kusuma, Dian, Kwan, Gene F., La Vecchia, Carlo, Lacey, Ben, Lallukka, Tea, Lan, Qing, Lasrado, Savita, Lassi, Zohra S., Lauriola, Paolo, Lawrence, Wayne R., Laxmaiah, Avula, LeGrand, Kate E., Li, Ming-Chieh, Li, Bingyu, Li, Shanshan, Lim, Stephen S., Lim, Lee-Ling, Lin, Hualiang, Lin, Ziqiang, Lin, Ro-Ting, Liu, Xuefeng, Lopez, Alan D., Lorkowski, Stefan, Lotufo, Paulo A., Lugo, Alessandra, M, Nirmal K., Madotto, Fabiana, Mahmoudi, Morteza, Majeed, Azeem, Malekzadeh, Reza, Malik, Ahmad A., Mamun, Abdullah A., Manafi, Navid, Mansournia, Mohammad Ali, Mantovani, Lorenzo G., Martini, Santi, Mathur, Manu R., Mazzaglia, Giampiero, Mehata, Suresh, Mehndiratta, Man Mohan, Meier, Toni, Menezes, Ritesh G., Meretoja, Atte, Mestrovic, Tomislav, Miazgowski, Bartosz, Miazgowski, Tomasz, Michalek, Irmina Maria, Miller, Ted R., Mirrakhimov, Erkin M., Mirzaei, Hamed, Moazen, Babak, Moghadaszadeh, Masoud, Mohammad, Yousef, Mohammad, Dara K., Mohammed, Shafiu, Mohammed, Mohammed A., Mokhayeri, Yaser, Molokhia, Mariam, Montasir, Ahmed A., Moradi, Ghobad, Moradzadeh, Rahmatollah, Moraga, Paula, Morawska, Lidia, Moreno Velásquez, Ilais, Morze, Jakub, Mubarik, Sumaira, Muruet, Walter, Musa, Kamarul Imran, Nagarajan, Ahamarshan J., Nalini, Mahdi, Nangia, Vinay, Naqvi, Atta Abbas, Narasimha Swamy, Sreenivas, Nascimento, Bruno R., Nayak, Vinod C., Nazari, Javad, Nazarzadeh, Milad, Negoi, Ruxandra I., Neupane Kandel, Sandhya, Nguyen, Huong L.T., Nixon, Molly R., Norrving, Bo, Noubiap, Jean Jacques, Nouthe, Brice E., Nowak, Christoph, Odukoya, Oluwakemi O., Ogbo, Felix A., Olagunju, Andrew T., Orru, Hans, Ortiz, Alberto, Ostroff, Samuel M., Padubidri, Jagadish Rao, Palladino, Raffaele, Pana, Adrian, Panda-Jonas, Songhomitra, Parekh, Utsav, Park, Eun-Cheol, Parvizi, Mojtaba, Pashazadeh Kan, Fatemeh, Patel, Urvish K., Pathak, Mona, Paudel, Rajan, Pepito, Veincent Christian F., Perianayagam, Arokiasamy, Perico, Norberto, Pham, Hai Q., Pilgrim, Thomas, Piradov, Michael A., Pishgar, Farhad, Podder, Vivek, Polibin, Roman V., Pourshams, Akram, Pribadi, Dimas R.A., Rabiee, Navid, Rabiee, Mohammad, Radfar, Amir, Rafiei, Alireza, Rahim, Fakher, Rahimi-Movaghar, Vafa, Ur Rahman, Mohammad Hifz, Rahman, Muhammad Aziz, Rahmani, Amir Masoud, Rakovac, Ivo, Ram, Pradhum, Ramalingam, Sudha, Rana, Juwel, Ranasinghe, Priyanga, Rao, Sowmya J., Rathi, Priya, Rawal, Lal, Rawasia, Wasiq F., Rawassizadeh, Reza, Remuzzi, Giuseppe, Renzaho, Andre M.N., Rezapour, Aziz, Riahi, Seyed Mohammad, Roberts-Thomson, Ross L., Roever, Leonardo, Rohloff, Peter, Romoli, Michele, Roshandel, Gholamreza, Rwegerera, Godfrey M., Saadatagah, Seyedmohammad, Saber-Ayad, Maha M., Sabour, Siamak, Sacco, Simona, Sadeghi, Masoumeh, Saeedi Moghaddam, Sahar, Safari, Saeed, Sahebkar, Amirhossein, Salehi, Sana, Salimzadeh, Hamideh, Samaei, Mehrnoosh, Samy, Abdallah M., Santos, Itamar S., Santric-Milicevic, Milena M., Sarrafzadegan, Nizal, Sarveazad, Arash, Sathish, Thirunavukkarasu, Sawhney, Monika, Saylan, Mete, Schmidt, Maria I., Schutte, Aletta E., Senthilkumaran, Subramanian, Sepanlou, Sadaf G., Sha, Feng, Shahabi, Saeed, Shahid, Izza, Shaikh, Masood A., Shamali, Mahdi, Shamsizadeh, Morteza, Shawon, Md Shajedur Rahman, Sheikh, Aziz, Shigematsu, Mika, Shin, Min-Jeong, Shin, Jae Il, Shiri, Rahman, Shiue, Ivy, Shuval, Kerem, Siabani, Soraya, Siddiqi, Tariq J., Silva, Diego A.S., Singh, Jasvinder A., Mtech, Ambrish Singh, Skryabin, Valentin Y., Skryabina, Anna A., Soheili, Amin, Spurlock, Emma E., Stockfelt, Leo, Stortecky, Stefan, Stranges, Saverio, Suliankatchi Abdulkader, Rizwan, Tadbiri, Hooman, Tadesse, Eyayou G., Tadesse, Degena B., Tajdini, Masih, Tariqujjaman, Md, Teklehaimanot, Berhane F., Temsah, Mohamad-Hani, Tesema, Ayenew K., Thakur, Bhaskar, Thankappan, Kavumpurathu R., Thapar, Rekha, Thrift, Amanda G., Timalsina, Binod, Tonelli, Marcello, Touvier, Mathilde, Tovani-Palone, Marcos R., Tripathi, Avnish, Tripathy, Jaya P., Truelsen, Thomas C., Tsegay, Guesh M., Tsegaye, Gebiyaw W., Tsilimparis, Nikolaos, Tusa, Biruk S., Tyrovolas, Stefanos, Umapathi, Krishna Kishore, Unim, Brigid, Unnikrishnan, Bhaskaran, Usman, Muhammad S., Vaduganathan, Muthiah, Valdez, Pascual R., Vasankari, Tommi J., Velazquez, Diana Z., Venketasubramanian, Narayanaswamy, Vu, Giang T., Vujcic, Isidora S., Waheed, Yasir, Wang, Yanzhong, Wang, Fang, Wei, Jingkai, Weintraub, Robert G., Weldemariam, Abrha H., Westerman, Ronny, Winkler, Andrea S., Wiysonge, Charles S., Wolfe, Charles D.A., Wubishet, Befikadu Legesse, Xu, Gelin, Yadollahpour, Ali, Yamagishi, Kazumasa, Yan, Lijing L., Yandrapalli, Srikanth, Yano, Yuichiro, Yatsuya, Hiroshi, Yeheyis, Tomas Y., Yeshaw, Yigizie, Yilgwan, Christopher S., Yonemoto, Naohiro, Yu, Chuanhua, Yusefzadeh, Hasan, Zachariah, Geevar, Zaman, Sojib Bin, Zaman, Muhammed S., Zamanian, Maryam, Zand, Ramin, Zandifar, Alireza, Zarghi, Afshin, Zastrozhin, Mikhail S., Zastrozhina, Anasthasia, Zhang, Zhi-Jiang, Zhang, Yunquan, Zhang, Wangjian, Zhong, Chenwen, Zou, Zhiyong, Zuniga, Yves Miel H., Murray, Christopher J.L., Fuster, Valentin, Barengo, Noël C., Beaton, Andrea Z., Bonny, Aimé, Carapetis, Jonathan, Chugh, Sumeet S., Criqui, Michael, DeCleene, Nicole, Fernández-Solà, Joaquim, Fowkes, Gerry, Kassebaum, Nicholas, Koroshetz, Walter, Temesgen, Awoke Misganaw, Mokdad, Ali, Moraes de Oliveira, Glaucia, Otto, Catherine, Owolabi, Mayowa, Reitsma, Marissa, Rigotti, Nancy, Sable, Craig, Shakil, Saate, Sliwa-Hahnle, Karen, Stark, Benjamin, Tleyjeh, Imad M., Zuhlke, Liesl, and Murray, Christopher

Published
2020
Full Text
View/download PDF

42. National Hypertension Taskforce of Australia: a roadmap to achieve 70% blood pressure control in Australia by 2030.

Author

Schutte, Aletta E, Bennett, Belinda, Chow, Clara K, Cloud, Geoffrey C, Doyle, Kerry, Girdis, Zoe, Golledge, Jonathan, Goodman, Andrew, Hespe, Charlotte M, Hsu, Meng P, James, Sharon, Jennings, Garry, Khan, Taskeen, Lee, Audrey, Murphy, Lisa, Nelson, Mark R, Nicholls, Stephen J, Raffoul, Natalie, Robson, Breonny, and Rodgers, Anthony

Published
2024
Full Text
View/download PDF

44. Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial

Author

Hagins, Debbie P., Osiyemi, Olayemi O., Prelutsky, David James, Ramgopal, Moti N., Scarsella, Anthony John, Dretler, Robin, DeJesus, Edwin, Bettacchi, Christopher J., Sims, James, III, Clay, Patrick G., Bellos, Nicholaos C., Thompson, Melanie A., Montero, Jose, McDonald, Cheryl K., Creticos, Catherine, Shamblaw, David, Mogyoros, Miguel, Terrelonge, Antonio E., Valdes, Martin, Tashima, Karen T., Robbins, William J., Felizarta, Franco Antonio, Elion, Richard A., Slim, Jihad, Win, Sandra S., Lalla-Reddy, Sujata N., Ruane, Peter Jerome, Mills, Anthony, Cade, Jerry L., Dietz, Craig A., Rubin, David Scott, Mayer, Cynthia, Rondon, Juan Carlos, Cook, Paul P., Daar, Eric, Kumar, Princy N., Swindells, Susan, Castro, Jose Guillermo, Melendez-Rivera, Ivan, Morales-Ramirez, Javier O., Santiago, Lizette, Santana-Bagur, Jorge L., Martins, Marcelo, Cahn, Pedro Enrique, Lopardo, Gustavo D., Porteiro, Norma, Bloch, Mark Theo, Baker, David Alfred, Roth, Norman, Moore, Richard James, Finlayson, Robert James, McMahon, James, Rieger, Armin, Zoufaly, Alexander, Hartl, Sylvia, Zangerle, Robert, Smaill, Fiona, Walmsley, Sharon L., Conway, Brian, Rachlis, Anita, Smith, Graham H.R., Perez, Carlos, Afani, Alejandro, Campos, Maria Isabel, Chahin, Carolina Eugenia, Wolff Reyes, Marcelo, Gerstoft, Jan, Weis, Nina, Laursen, Alex Lund, Molina, Jean-Michel, Yazdanpanah, Yazdan, Cotte, Laurent, Raffi, Francois, Morlat, Philippe, Girard, Pierre-Marie, Katlama, Christine, Rockstroh, Juergen K., Arasteh, Keikawus, Esser, Stefan, Stoehr, Albrecht, Stellbrink, Hans-Juergen, Stoll, Matthias, Schuermann, Dirk, Faetkenheuer, Gerd, Bogner, Johannes, Lutz, Thomas, Baumgarten, Axel, Jaeger, Hans, Gori, Andrea, Coltan, Gabriel, Constandis, Felicia, Erscoiu, Simona Manuela, Prisacariu, Liviu-Jany, Rugina, Sorin, Streinu-Cercel, Adrian, Pokrovsky, Vadim Valentinovich, Zakharova, Natalia V., Shuldyakov, Andrey Anatolyevich, Ryamova, Elena Pavlovna, Kulagin, Valeriy Viktorovich, Tsybakova, Olga Aleksandrovna, Orlova-Morozova, Elena, Nagimova, Firaya, Voronin, Evgeniy, Shimonova, Tatyana Evgenyevna, Kozyrev, Oleg Anatolyevich, Orrell, Catherine, Lombaard, Johannes Jurgens, de Jager, Marleen, Portilla Segorb, Joaquin, Mallolas, Josep, Perez Elias, Maria Jesus, Gatell, Josep M., Arribas Lopez, Jose Ramon, Negredo Puigmal, Eugenia, Podzamczer Palter, Daniel, Pulido Ortega, Federico, Troya Garcia, Jesus, De los Santos Gil, Ignacio, Berenguer Berenguer, Juan, Williams, Ian G., Johnson, Margaret A., Schembri, Gabriel, Clarke, Amanda, Gompels, Mark, Fox, Julie Meriel, Taylor, Steven John, Dockrell, David Harold, Kegg, Stephen, Squires, Kathleen, Sax, Paul E, Cahn, Pedro, Lombaard, Johan, Lai, Ming-Tain, Rodgers, Anthony, Lupinacci, Lisa, Kumar, Sushma, Sklar, Peter, Hanna, George J, Hwang, Carey, and Martin, Elizabeth Anne

Published
2020
Full Text
View/download PDF

47. Rationale for a New Low-Dose Triple Single Pill Combination for the Treatment of Hypertension

Author

Rodgers, Anthony, primary, Salam, Abdul, additional, Cushman, William, additional, de Silva, Asita, additional, Di Tanna, Gian Luca, additional, Gnanenthiran, Sonali R., additional, Grobbee, Diederick, additional, Narkiewicz, Krzysztof, additional, Ojji, Dike, additional, Oparil, Suzanne, additional, Poulter, Neil, additional, Schlaich, Markus P., additional, Schutte, Aletta E., additional, Spiering, Wilko, additional, Williams, Bryan, additional, Wright, Jackson T., additional, and Whelton, Paul, additional

Published
2024
Full Text
View/download PDF

49. Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35–74 Years

Author

Moise, Nathalie, Huang, Chen, Rodgers, Anthony, Kohli-Lynch, Ciaran N, Tzong, Keane Y, Coxson, Pamela G, Bibbins-Domingo, Kirsten, Goldman, Lee, and Moran, Andrew E

Subjects
Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Clinical Sciences, Health Services, Hypertension, Patient Safety, Clinical Research, Heart Disease, Cardiovascular, Comparative Effectiveness Research, Prevention, Cost Effectiveness Research, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Good Health and Well Being, Adult, Age Factors, Aged, Antihypertensive Agents, Blood Pressure Determination, Cardiovascular Diseases, Conservative Treatment, Cost-Benefit Analysis, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Health Care Costs, Health Policy, Humans, Male, Markov Chains, Middle Aged, Policy Making, Practice Guidelines as Topic, Quality-Adjusted Life Years, Risk Assessment, United States, cardiovascular diseases, cost-benefit analysis, hypertension, guideline, policy, Cardiorespiratory Medicine and Haematology, Public Health and Health Services, Cardiovascular System & Hematology, Cardiovascular medicine and haematology, Clinical sciences
Abstract

The population health effect and cost-effectiveness of implementing intensive blood pressure goals in high-cardiovascular disease (CVD) risk adults have not been described. Using the CVD Policy Model, CVD events, treatment costs, quality-adjusted life years, and drug and monitoring costs were simulated over 2016 to 2026 for hypertensive patients aged 35 to 74 years. We projected the effectiveness and costs of hypertension treatment according to the 2003 Joint National Committee (JNC)-7 or 2014 JNC8 guidelines, and then for adults aged ≥50 years, we assessed the cost-effectiveness of adding an intensive goal of systolic blood pressure

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results